E85.3
BillableSecondary systemic amyloidosis
Secondary systemic amyloidosis
Coding Notes
Inclusion Terms
Alternative clinical terms for this condition
- Hemodialysis-associated amyloidosis
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
Excludes 2
Conditions not included here, but the patient may have both
Related Codes(6)
ICD-11 Equivalents(1)
ICD-11 Equivalents
View full mappingCorresponding ICD-11 codes from the WHO crosswalk mapping
Also Known As / Clinical Terms(69)
SNOMED CT
- Beta-2 microglobulin amyloidosis32599008
- Dialysis-associated amyloidosis32599008
- Haemodialysis-associated amyloidosis32599008
- Hemodialysis-associated amyloidosis32599008
- beta-2-Microglobulin amyloidosis32599008
- Complication of haemodialysis85223007
- Complication of hemodialysis85223007
- CAA - Cerebral amyloid angiopathy230724001
- Cerebral amyloid angiopathy230724001
- Congophilic angiopathy230724001
- Long-term disorder of dialysis236542001
- AA amyloidosis274945004
- Amyloid A amyloidosis274945004
- Amyloid of familial Mediterranean fever367528006
- Amyloidosis due to familial Mediterranean fever367528006
- Secondary systemic amyloidosis affecting skin (AA fibril type)402457007
- Haemodialysis-associated secondary amyloidosis of skin402458002
- Hemodialysis-associated secondary amyloidosis of skin402458002
- Systemic amyloidosis affecting skin402719006
- Dialysis spondyloarthropathy707090004
- Spondyloarthropathy due to hemodialysis-associated amyloidosis707090004
- Secondary systemic amyloidosis858580008
- Cerebral secondary systemic amyloid angiopathy1187538003
- Secondary systemic amyloid angiopathy of cerebrum1187538003
- Cardiac secondary systemic amyloidosis1187540008
- Secondary systemic amyloidosis of heart1187540008
- Disorder of glomerulus due to secondary systemic amyloidosis1187553006
- Glomerular disorder due to secondary systemic amyloidosis1187553006
- Disorder of glomerulus due to amyloidosis1187557007
- Glomerular disorder due to amyloidosis1187557007
UMLS
- Beta-2 microglobulin amyloidosisC0268405
- Dialysis-associated amyloidosisC0268405
- Haemodialysis-associated amyloidosisC0268405
- Hemodialysis-associated amyloidosisC0268405
- Hemodialysis-associated amyloidosis (disorder)C0268405
- beta-2-Microglobulin amyloidosisC0268405
- Secondary systemic amyloidosisC3536716
- Secondary systemic amyloidosis (disorder)C3536716
Clinical Terms
- AA amyloidosis
- Hemodialysis-associated amyloidosis
- Amyloid of familial Mediterranean fever
- Secondary systemic amyloidosis affecting skin (AA fibril type)
- Glomerular disorder due to amyloidosis
- Amyloid A amyloidosis
- beta-2-Microglobulin amyloidosis
- CAA - Cerebral amyloid angiopathy
- Amyloidosis due to familial Mediterranean fever
- Systemic amyloidosis affecting skin
- Disorder of glomerulus due to secondary systemic amyloidosis
- Disorder of glomerulus due to amyloidosis
- Glomerular disorder due to secondary systemic amyloidosis
- Dialysis-associated amyloidosis
- Haemodialysis-associated amyloidosis
- Complication of haemodialysis
- Hemodialysis-associated amyloidosis (disorder)
- Cardiac secondary systemic amyloidosis
- Secondary systemic amyloid angiopathy of cerebrum
- Cerebral secondary systemic amyloid angiopathy
- Cerebral amyloid angiopathy
- Secondary systemic amyloidosis of heart
- Hemodialysis-associated secondary amyloidosis of skin
- Congophilic angiopathy
- Haemodialysis-associated secondary amyloidosis of skin
- Spondyloarthropathy due to hemodialysis-associated amyloidosis
- Dialysis spondyloarthropathy
- Secondary systemic amyloidosis (disorder)
- Beta-2 microglobulin amyloidosis
- Complication of hemodialysis
- Long-term disorder of dialysis
Frequently Asked Questions
What is the ICD-10 code for secondary systemic amyloidosis?
The ICD-10-CM code for secondary systemic amyloidosis is E85.3. The full clinical description is "Secondary systemic amyloidosis". E85.3 is a billable/specific code that can be used on insurance claims and medical billing.
What does ICD-10 code E85.3 mean?
ICD-10-CM code E85.3 represents “Secondary systemic amyloidosis”. It is classified under Chapter 4: Endocrine, Nutritional and Metabolic Diseases and is a billable/specific code that can be used on a claim.
Is E85.3 a billable code?
Yes, E85.3 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.
What chapter is E85.3 in?
E85.3 is in Chapter 4: Endocrine, Nutritional and Metabolic Diseases (codes E00-E89).
What codes cannot be used with E85.3?
E85.3 has Excludes1 notes indicating codes that cannot be used together with it, including: transitory endocrine and metabolic disorders specific to newborn (P70-P74); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); and 3 more.
What SNOMED CT codes does E85.3 map to?
E85.3 maps to 15 SNOMED CT concepts: 274945004, 367528006, 32599008, 230724001, 1187540008, and 10 more. SNOMED CT is a clinical terminology used in electronic health records.
What are the UMLS CUIs for E85.3?
E85.3 is linked to 2 UMLS Concept Unique Identifiers: C0268405, C3536716. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does E85.3 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like secondary systemic amyloidosis affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of E85.3?
E85.3 maps to the ICD-11 code: 5D00.1 (AA amyloidosis).
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.